The results showed that pretreatment with 4-IPP significantly inhibited the pro-proliferative effects of CD81+ Erys on AML cell proliferation, confirming MIF’s essential role in this process (Figure 5A). The gene discussed is CD81; the disease is acute myeloid leukemia.